Stanford University
Showing 22,191-22,200 of 37,204 Results
-
Esmeralda Morales
Clinical Associate Professor, Pediatrics - Pulmonary Medicine
BioEsmeralda Morales, MD is a Board-Certified Pediatric Pulmonologist who earned her medical degree from Baylor College of Medicine. She completed her subspecialty training in Pediatric Pulmonology at the University of Arizona/Arizona Respiratory Center known for its excellence in asthma care and research. She practiced in the southwestern United States for 7 years including a year as Interim Chief of the Pediatric Pulmonary Division at the University of New Mexico and was a former University of New Mexico Cystic Fibrosis Center Director, as well as co-chair of the New Mexico Council on Asthma. She has been a member of the Pediatric Pulmonary Division through the Stanford University School of Medicine for the past 7 years and is leading asthma clinical efforts in the division. Her main areas of interest are childhood asthma, aerodigestive disorders in children, respiratory disorders in children with complex healthcare needs and the care of historically marginalized patient populations.
-
Luis Miguel Morales
Affiliate, Med/Program/Bedside Med
BioLuis Morales is a medical student at Howard University College of Medicine with a strong interest in neurosurgery, neuro-oncology, and translational cancer research. As an undergraduate at the University of Florida, he conducted research focused on glioblastoma and personalized cancer immunotherapy. His work emphasized bioinformatic approaches with the goal of identifying biologically relevant targets for treatment. Through this research, he developed skills in advanced coding techniques, pipeline development, database parsing, scientific writing, and translational research. This summer at Stanford, Luis is studying leptomeningeal disease and brain tumor biology using RNA sequencing and spatial transcriptomic approaches. His research aims to better understand tumor invasion and the tumor microenvironment while identifying molecular patterns that could support future therapeutic strategies for aggressive central nervous system tumors.
